Crescent Biopharma Inc (CBIO) PT Raised to $32 at Stifel
Tweet Send to a Friend
Stifel analyst Stephen Willey raised the price target on Crescent Biopharma Inc (NASDAQ: CBIO) to $32.00 (from $28.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
